MARKET NEWS

 

Xalud Therapeutics’ Lead Candidate Achieves Multiple Clinical Milestones in Pathologic Inflammation & Neuroimmunology Therapeutic Areas
VBL Therapeutics to Provide Update on OVAL Phase 3 Registration Enabling Study of VB-111 in Ovarian Cancer
Onconova Therapeutics Announces Initial Dosing of First Patient in US Phase 1 Clinical Trial 
The Discovery Labs Signs Foundational Lease With the University of Pennsylvania Gene Therapy Program as Anchor Tenant
CatalYm to Present Initial Data of First-in-Human Trial of GDF-15 Neutralizing Antibody CTL-002 
Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity With New Multi-Purpose Fill Suite

  FEATURED EDITORIAL

  COMPANY PROFILE

Pfizer CentreOne is a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support, and long-term supply. For more than 40 years, we’ve been guiding complex compounds securely and efficiently from development through commercial manufacture. Working together with our customers, we combine our knowledge with open dialogue to solve challenges. Intelligent collaboration with Pfizer CentreOne. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Microfluidics: An Alternative Method for Developing Nanoparticle Drug Delivery Systems

Microfluidics: An Alternative Method for Developing Nanoparticle Drug Delivery Systems

The encapsulation of drugs within purposely formulated liposome nanoparticles offers the potential for more controlled and sustained release, as well as reducing toxicity and….

Stevanato Group & Corning Incorporated Sign Licensing Agreement to Offer Corning Valor Glass Vials in Presterilized SG EZ-fill Packaging Configuration

Stevanato Group & Corning Incorporated Sign Licensing Agreement to Offer Corning Valor Glass Vials in Presterilized SG EZ-fill Packaging Configuration

Stevanato Group recently announced a licensing agreement with Corning Incorporated to offer a combined solution that will provide biopharmaceutical companies with improved levels of….

Evonik Markets New Enteric-Protected Ready-to-Fill Capsules for Fast, High-Performance Drug Development

Evonik Markets New Enteric-Protected Ready-to-Fill Capsules for Fast, High-Performance Drug Development

Evonik  recently launched the EUDRACAP platform of easy-to-handle capsules to help the pharmaceutical industry accelerate speed to market for complex oral drug products in early development stages…..

Myriad Genetics Signs Definitive Agreement to Sell Myriad RBM to Q2 Solutions

Myriad Genetics Signs Definitive Agreement to Sell Myriad RBM to Q2 Solutions

Myriad Genetics, Inc. recently announced it has signed a definitive agreement to sell Myriad RBM, Inc. to Q2 Solutions, a leading global clinical trial laboratory services organization….

Ginkgo Bioworks & Biogen Announce Collaboration & License Agreement to Develop Novel Gene Therapy Manufacturing Platform

Ginkgo Bioworks & Biogen Announce Collaboration & License Agreement to Develop Novel Gene Therapy Manufacturing Platform

Ginkgo Bioworks and Biogen recently announced a gene therapy collaboration in which the companies aim to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

June 9 – Injection Devices
June 16 – Parenteral Contract Manufacturing